Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis Suppurativa

Explore clinical trials studying Hidradenitis Suppurativa. Study availability and eligibility vary by location and protocol.

157 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis Suppurativa trial results

Active, Not Recruiting

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06046729

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Saguaro Dermatology Associates, LLC - Probity - PPDS Phoenix, Arizona, United States
  • Arkansas Research Trials, LLC North Little Rock, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04901195

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Hs0005 50140 Birmingham, Alabama, United States
  • Hs0005 50175 Phoenix, Arizona, United States
  • Hs0005 50162 Fountain Valley, California, United States
  • Hs0005 50161 Los Angeles, California, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

NCT06785675

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Ras al-Khaimah, United Arab Emirates
  • Novartis Investigative Site Sharjah city, United Arab Emirates
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • CTT Research Gilbert, Arizona, United States
  • Ctr Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Ctr for Dermatology Clinical Res Fremont, California, United States
View all 131 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

NCT06799000

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Cheryl Effron MD Inc Anaheim, California, United States
View all 138 locations
View Trial Details
Active, Not Recruiting

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

NCT06768671

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Stanford, California, United States
  • Clinical Site Washington D.C., District of Columbia, United States
  • Clinical Site Hollywood, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

NCT06517732

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Izhevsk, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kazan', Russia
View all 19 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

NCT04179175

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Northwest Arkansas Center Rogers, Arkansas, United States
  • MedDerm Associates San Diego, California, United States
  • University Clinical Trials San Diego, California, United States
  • Southern California Skin and Laser Whittier, California, United States
View all 191 locations
View Trial Details

Related conditions